Stocktoria
Cytek Biosciences, Inc. CTKB
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2021-07-23
Chart by TradingView
3/9
Piotroski F — financial health
6.15
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $201.5M | $200.5M | $193.0M | $164.0M | $128.0M |
| Gross profit | $104.5M | $111.1M | $109.4M | $101.0M | $79.1M |
| Operating income | -$40.4M | -$20.5M | -$27.8M | -$1.8M | $9.2M |
| Net income | -$66.5M | -$6.0M | -$12.1M | $2.5M | $3.0M |
| Operating cash flow | -$4.7M | $25.4M | $5.3M | -$12.2M | $4.6M |
| Free cash flow | -$8.8M | $21.9M | $633,000 | -$22.0M | $266,000 |
| Total assets | $461.5M | $499.5M | $494.5M | $519.5M | $463.3M |
| Total liabilities | $119.8M | $103.8M | $101.4M | $93.9M | $57.9M |
| Shareholders' equity | $341.7M | $395.7M | $393.1M | $425.5M | $405.4M |
| Ratios | |||||
| Gross margin | 51.8% | 55.4% | 56.7% | 61.6% | 61.9% |
| Operating margin | -20.0% | -10.2% | -14.4% | -1.1% | 7.2% |
| Net margin | -33.0% | -3.0% | -6.3% | 1.5% | 2.4% |
| FCF margin | -4.4% | 10.9% | 0.3% | -13.4% | 0.2% |
| Return on assets | -14.4% | -1.2% | -2.5% | 0.5% | 0.7% |
| Return on equity | -19.5% | -1.5% | -3.1% | 0.6% | 0.7% |
| Current ratio | 5.04 | 5.86 | 6.97 | 9.26 | 13.01 |
| Revenue growth | 0.5% | 3.9% | 17.7% | 28.2% | 37.8% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 676,700 | $3.0M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 6.15 (safe)
- Working capital / assets 0.681
- Retained earnings / assets -0.22
- EBIT / assets -0.087
- Equity / liabilities 2.853
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001831915 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.